-
1
-
-
0033256269
-
New cases seen at genitourinary medicine clinics: England 1998
-
Lamagmi TL, Hughes G, Rogers PA, et al: New cases seen at genitourinary medicine clinics: England 1998. Comm Dis Report 1998, 9 (Suppl 6):1-12
-
(1998)
Comm. Dis. Report
, vol.9
, Issue.SUPPL. 6
, pp. 1-12
-
-
Lamagmi, T.L.1
Hughes, G.2
Rogers, P.A.3
-
2
-
-
0032907880
-
New approaches to the management of external genital warts
-
Richwald GA, Reitano M: New approaches to the management of external genital warts. Infect Dis Clin Pract 1999, 8:67-75
-
(1999)
Infect. Dis. Clin. Pract.
, vol.8
, pp. 67-75
-
-
Richwald, G.A.1
Reitano, M.2
-
3
-
-
0033918893
-
European course on HPV associated pathology: Guidelines for primary care physicians for the diagnosis and management of anogenital warts
-
von Krogh G, Lacey CJ, Gross G, et al: European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts. Sex Transm Inf 2000, 76:162-8
-
(2000)
Sex. Transm. Inf.
, vol.76
, pp. 162-168
-
-
von Krogh, G.1
Lacey, C.J.2
Gross, G.3
-
4
-
-
2942548462
-
New guidelines assist GP management of anogenital warts
-
Lacey C: New guidelines assist GP management of anogenital warts. Guidelines in Practice 2001, 3:25-30
-
(2001)
Guidelines in Practice
, vol.3
, pp. 25-30
-
-
Lacey, C.1
-
5
-
-
0342464432
-
National guideline for the management of anogenital warts
-
Clinical Effectiveness Group (Association of Genitourinary Medicine and Medical Society for the study of Venereal Disease)
-
Clinical Effectiveness Group (Association of Genitourinary Medicine and Medical Society for the study of Venereal Disease) : National guideline for the management of anogenital warts. Sex Transm Inf 1999, 75 (Suppl 1):S71-5
-
(1999)
Sex. Transm. Inf.
, vol.75
, Issue.SUPPL. 1
-
-
-
6
-
-
0003188329
-
Guidelines for treatment of sexually transmitted diseases
-
Centres for Disease Control and Prevention.: (RR-1)
-
Centres for Disease Control and Prevention. : Guidelines for treatment of sexually transmitted diseases. MMWR 1998, 47(RR-1):1-111
-
(1998)
MMWR
, vol.47
, pp. 1-111
-
-
-
7
-
-
0003188329
-
1998 guidelines for treatment of sexually transmitted diseases
-
Centres for Disease Control and Prevention
-
Centres for Disease Control and Prevention. : 1998 guidelines for treatment of sexually transmitted diseases. MMWR 1997, 47:88-95
-
(1997)
MMWR
, vol.47
, pp. 88-95
-
-
-
8
-
-
0030972456
-
Using numerical results from systematic reviews in clinical practice
-
McQuay HJ, Moore RA: Using numerical results from systematic reviews in clinical practice. Ann Intern Med 1997, 126:712-720
-
(1997)
Ann. Intern. Med.
, vol.126
, pp. 712-720
-
-
McQuay, H.J.1
Moore, R.A.2
-
9
-
-
0003533136
-
An evidence-based resource for pain relief
-
Oxford. Oxford University Press ISBN 0-19-262718-X
-
McQuay HJ, Moore RA: An evidence-based resource for pain relief. Oxford. Oxford University Press 1998, ISBN 0-19-262718-X:
-
(1998)
-
-
McQuay, H.J.1
Moore, R.A.2
-
10
-
-
0001793860
-
Mechanism of action of Imiquimod
-
Stanley MA: Mechanism of action of Imiquimod. Papillomavirus Report 1999, 10:23-29
-
(1999)
Papillomavirus Report
, vol.10
, pp. 23-29
-
-
Stanley, M.A.1
-
11
-
-
0033610734
-
Improving the quality of reports of meta-analyses of randomised controlled trials: The QUORUM statement
-
Moher D, Cook DJ, Eastwood S, et al: Improving the quality of reports of meta-analyses of randomised controlled trials: the QUORUM statement. Lancet 1999, 354:1896-1900
-
(1999)
Lancet
, vol.354
, pp. 1896-1900
-
-
Moher, D.1
Cook, D.J.2
Eastwood, S.3
-
12
-
-
0029914622
-
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
-
Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, McQuay HJ: Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trial 1996, 17:1-12
-
(1996)
Control Clin. Trial
, vol.17
, pp. 1-12
-
-
Jadad, A.R.1
Moore, R.A.2
Carroll, D.3
Jenkinson, C.4
Reynolds, D.J.M.5
Gavaghan, D.J.6
McQuay, H.J.7
-
13
-
-
0035941525
-
Completeness of safety reporting in randomized trials. An evaluation of 7 medical areas
-
Ioannidis JP, Lau J: Completeness of safety reporting in randomized trials. An evaluation of 7 medical areas. JAMA 2001, 285:437-443
-
(2001)
JAMA
, vol.285
, pp. 437-443
-
-
Ioannidis, J.P.1
Lau, J.2
-
14
-
-
0023049334
-
Confidence intervals rather than P values: Estimation rather than hypothesis testing
-
Gardner MJ, Altman DG: Confidence intervals rather than P values: estimation rather than hypothesis testing. BMJ 1986, 292:746-50
-
(1986)
BMJ
, vol.292
, pp. 746-750
-
-
Gardner, M.J.1
Altman, D.G.2
-
15
-
-
0001019181
-
Calculating confidence intervals for relative risk, odds ratios and standardised ratios and rates
-
Edited by Gardner, MJ and Altman DG. London: British Medical Journal
-
Morris JA, Gardner MJ: Calculating confidence intervals for relative risk, odds ratios and standardised ratios and rates. In Statistics with confidence - confidence intervals and statistical guidelines. Edited by Gardner, MJ and Altman DG. London: British Medical Journal, 199550-63
-
(1995)
In Statistics With Confidence - Confidence Intervals and Statistical Guidelines
, pp. 50-63
-
-
Morris, J.A.1
Gardner, M.J.2
-
16
-
-
0034175511
-
An evaluation of homogeneity tests in meta-analyses in pain using simulations of individual patient data
-
Gavaghan DJ, Moore RA, McQuay HJ: An evaluation of homogeneity tests in meta-analyses in pain using simulations of individual patient data. Pain 2000, 85:415-424
-
(2000)
Pain
, vol.85
, pp. 415-424
-
-
Gavaghan, D.J.1
Moore, R.A.2
McQuay, H.J.3
-
17
-
-
0034192326
-
Misleading funnel plot for detection of bias in meta-analysis
-
J Tang, JL Liu: Misleading funnel plot for detection of bias in meta-analysis. J Clin Epidemiol 2000, 53:477-484
-
(2000)
J. Clin. Epidemiol.
, vol.53
, pp. 477-484
-
-
Tang, J.1
Liu, J.L.2
-
18
-
-
0033667445
-
Publication and related bias in meta-analysis. Power of statistical tests and prevalence in the literature
-
Sterne JA, Gavaghan D, Egger M: Publication and related bias in meta-analysis. Power of statistical tests and prevalence in the literature . J Clin Epidemiol 2000, 53:1119-29
-
(2000)
J. Clin. Epidemiol.
, vol.53
, pp. 1119-1129
-
-
Sterne, J.A.1
Gavaghan, D.2
Egger, M.3
-
19
-
-
0028908929
-
The number needed to treat: A clinically useful measure of treatment effect
-
Cook RJ, Sackett DL: The number needed to treat: a clinically useful measure of treatment effect. BMJ 1995, 310:452-4
-
(1995)
BMJ
, vol.310
, pp. 452-454
-
-
Cook, R.J.1
Sackett, D.L.2
-
20
-
-
0030931611
-
Effect of covert duplicate publication on meta-analysis; a case study
-
Tramèr M, Reynolds DJM, Moore RA, McQuay HJ: Effect of covert duplicate publication on meta-analysis; a case study. BMJ 1997, 315:635-40
-
(1997)
BMJ
, vol.315
, pp. 635-640
-
-
Tramèr, M.1
Reynolds, D.J.M.2
Moore, R.A.3
McQuay, H.J.4
-
21
-
-
0031976655
-
Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts
-
Beutner KR, Tyring SK, Trofatter KF, et al: Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts. Antimicrobial Agents and Chemotherapy 1998, 42:789-794
-
(1998)
Antimicrobial Agents and Chemotherapy
, vol.42
, pp. 789-794
-
-
Beutner, K.R.1
Tyring, S.K.2
Trofatter, K.F.3
-
22
-
-
0031937435
-
Treatment of genital warts with an immune-response modifier (imiquimod)
-
Beutner KR, Spruance SL, Hougham AJ, et al: Treatment of genital warts with an immune-response modifier (imiquimod). J AM Acad Dermatol 1998, 38:230-239
-
(1998)
J. AM. Acad. Dermatol.
, vol.38
, pp. 230-239
-
-
Beutner, K.R.1
Spruance, S.L.2
Hougham, A.J.3
-
23
-
-
0031886680
-
Self-administered topical 5% imiquimod cream for external anogenital warts
-
Edwards L, Ferenczy A, Eron L, et al: Self-administered topical 5% imiquimod cream for external anogenital warts. Arch Dermatol 1998, 134:25-30
-
(1998)
Arch. Dermatol.
, vol.134
, pp. 25-30
-
-
Edwards, L.1
Ferenczy, A.2
Eron, L.3
-
24
-
-
0032778213
-
A randomized,controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients
-
Gilson RJ, Shupack JL, Fried-Kien AE, et al: A randomized,controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients. AIDS 1999, 13:2397-2404
-
(1999)
AIDS
, vol.13
, pp. 2397-2404
-
-
Gilson, R.J.1
Shupack, J.L.2
Fried-Kien, A.E.3
-
25
-
-
0031853904
-
A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod
-
Tyring SK, Arany I, Stanley MA, et al: A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod. J Infect Dis 1998, 178:551-555
-
(1998)
J. Infect. Dis.
, vol.178
, pp. 551-555
-
-
Tyring, S.K.1
Arany, I.2
Stanley, M.A.3
-
26
-
-
0031827261
-
Management of female genital warts with an analog of imiquimod 2% in cream: A randomized, double-blind, placebo-controlled study
-
Syed T, Ahmadpour OA, Ahmad SA, Ahmad SH: Management of female genital warts with an analog of imiquimod 2% in cream: a randomized, double-blind, placebo-controlled study. J Dermatol 1998, 25:429-433
-
(1998)
J. Dermatol.
, vol.25
, pp. 429-433
-
-
Syed, T.1
Ahmadpour, O.A.2
Ahmad, S.A.3
Ahmad, S.H.4
-
27
-
-
0035147016
-
Safety and efficacy of imiquimod 5% cream in the treatment of penile genital warts in uncircumcised men when applied three times weekly or once per day
-
Gollnick H, Barasso R, Jappe U, et al: Safety and efficacy of imiquimod 5% cream in the treatment of penile genital warts in uncircumcised men when applied three times weekly or once per day. Int J STD & AIDS 2001, 12:22-28
-
(2001)
Int. J. STD & AIDS
, vol.12
, pp. 22-28
-
-
Gollnick, H.1
Barasso, R.2
Jappe, U.3
-
28
-
-
0032694314
-
Reporting of adverse effects in clinical trials should be improved. Lessons from acute postoperative pain
-
Edwards JE, McQuay HJ, Moore RA, Collins SL: Reporting of adverse effects in clinical trials should be improved. Lessons from acute postoperative pain. J Pain Symptom Manag 1999, 18:427-37
-
(1999)
J. Pain Symptom Manag.
, vol.18
, pp. 427-437
-
-
Edwards, J.E.1
McQuay, H.J.2
Moore, R.A.3
Collins, S.L.4
-
29
-
-
0029983193
-
The importance of quality of primary studies in producing unbiased systematic reviews
-
Khan KS, Daya S, Jadad AR: The importance of quality of primary studies in producing unbiased systematic reviews. Arch Intern Med 1996, 156:661-6
-
(1996)
Arch. Intern. Med.
, vol.156
, pp. 661-666
-
-
Khan, K.S.1
Daya, S.2
Jadad, A.R.3
-
30
-
-
0032558314
-
Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?
-
Moher D, Pham B, Jones A, et al: Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998, 352:609-613
-
(1998)
Lancet
, vol.352
, pp. 609-613
-
-
Moher, D.1
Pham, B.2
Jones, A.3
-
31
-
-
0032423803
-
Size is everything - Large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects
-
Moore RA, Gavaghan D, Tramèr MR, et al: Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain 1998, 78:217-220
-
(1998)
Pain
, vol.78
, pp. 217-220
-
-
Moore, R.A.1
Gavaghan, D.2
Tramèr, M.R.3
-
32
-
-
0003429386
-
Trends in sexually transmitted infections in the United Kingdom, 1990-1999
-
PHLS, DHSS&PS and the Scottish ISD(S)5 Collaborative Group. : London: Public Health Laboratory Service
-
PHLS, DHSS&PS and the Scottish ISD(S)5 Collaborative Group. : Trends in sexually transmitted infections in the United Kingdom, 1990-1999. London: Public Health Laboratory Service, 2000
-
(2000)
-
-
|